Kintara Therapeutics KTRA
€ 7.15
3179.25%
Quartalsbericht 2024-Q3
hinzugefügt 14.11.2024
Kintara Therapeutics Kennzahlen 2011-2024 | KTRA
Kennzahlen Jährlich Kintara Therapeutics
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.6 | -0.4 | -0.0 | - | - | - | - | - | - | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-0.3 | -9.3 | -25.8 | -1.6 | -0.9 | 3.2 | 5.4 | 7.4 | 0.8 | 0.5 | -0.2 | -0.3 | -0.2 | -0.2 |
EV (Enterprise Value) |
2.81 M | 7.67 M | -7.51 M | -7.58 M | -2.39 M | -1.65 M | -4.33 M | -5.25 M | -4.66 M | 309 K | -4.76 M | 1 M | -7.8 K | -15 K |
EBITDA per Share |
- | 0.04 | 0.06 | - | - | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
-252.5 | - | - | - | - | - | - | - | - | - | - | |||
PEG |
- | - | - | - | - | - | - | - | - | - | - | |||
P/B |
1.4 | 8.2 | 0.0 | - | - | - | - | - | - | - | - | - | - | - |
P/CF |
-0.7 | -0.5 | -0.0 | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-221.45 | -2003.97 | -192.12 | -361.95 | - | - | - | - | - | - | - | - | - | - |
ROA % |
-134.15 | -368.16 | -142.09 | -282.79 | - | - | - | - | - | - | - | - | - | - |
ROCE % |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
2.5 | 1.2 | 3.8 | 4.6 | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Kennzahlen Vierteljährlich Kintara Therapeutics
2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.37 | -0.05 | -0.24 | -63.92 | -1.94 | -2.1 | -3.39 | -5.42 | -5.45 | -6.07 | -0.25 | -17.3 | -0.23 | 0.22 | -1.33 | 0.22 | 1.33 | 0.15 | 0.21 | 0.15 | 0.21 | 0.75 | 0.88 | 0.08 | 0.09 | 0.14 | 0.18 | 0.14 | 0.18 | 0.13 | 0.23 | 0.36 | 0.23 | 0.06 | 0.15 | 0.1 | 0.04 | 0.02 | 0.04 | 0.03 | 0.04 | 0.03 | -0.22 | -0.22 | -0.3 | - | -0.03 | - | -0.03 | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | - | 0.04 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.02 | - | - | - | - |
ROE % |
608.53 | 649.81 | 631.42 | -40.15 | -254.60 | -225.45 | -214.89 | -198.23 | -242.06 | -226.16 | -215.16 | -295.02 | -213.72 | -267.52 | -268.48 | -186.79 | -187.76 | -115.66 | -149.26 | -174.22 | -207.82 | -239.23 | -205.55 | -171.92 | -154.63 | -140.90 | -158.15 | -195.14 | -221.43 | -228.03 | 2088.27 | 2461.03 | 3054.93 | 3299.44 | 1002.36 | 396.08 | -242.96 | -290.15 | -366.32 | 2157.61 | 2330.22 | 3085.35 | 3191.46 | 990.90 | 942.68 | 37.67 | 38.67 | -49.98 | 212.74 | 176.36 | -56.43 | 267.61 | -36.07 |
ROA % |
-334.02 | -330.25 | -338.07 | -318.59 | -168.52 | -161.95 | -160.38 | -152.29 | -189.38 | -182.72 | -175.88 | -233.56 | -330.23 | -959.37 | -959.69 | -894.51 | -753.37 | -128.81 | -146.90 | -169.63 | -152.11 | -140.49 | -121.55 | -98.07 | -112.45 | -118.00 | -128.90 | -155.83 | -172.70 | -175.03 | -17.10 | -34.67 | -143.56 | -122.54 | -258.70 | -229.47 | -27.22 | -0.79 | 34.27 | -57.99 | -183.99 | -381.88 | -403.71 | -511.73 | -442.80 | -273.61 | -1627.86 | -1450.28 | -1516.79 | -1550.59 | -56.43 | -102.07 | -36.07 |
ROCE % |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.24 | 0.49 | 0.80 | 1.12 | 5.77 | 6.77 | -49.98 | 217.08 | 176.36 | -56.43 | 267.61 | -36.07 |
Current Ratio |
1.7 | 4.9 | 0.9 | 0.4 | 2.3 | 3.0 | 3.7 | 3.8 | 3.8 | 4.9 | 7.0 | 4.6 | 6.9 | 7.1 | 9.0 | 1.1 | 1.1 | 6.3 | 6.2 | 1.9 | 1.9 | 3.2 | 4.4 | 4.3 | 4.3 | 5.5 | 9.4 | 5.9 | 5.9 | 4.0 | 4.7 | 4.2 | 4.2 | 1.1 | 0.7 | 0.8 | - | 2.0 | 1.1 | 0.8 | 1.2 | 0.8 | 0.9 | 0.5 | 0.8 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung